甲状旁腺激素及其检测方法新进展被引量：5

下载PDF

导出

摘要甲状旁腺激素（parathyroid hormone,PTH）是由甲状旁腺分泌的具有调节血钙磷代谢及骨健康的重要激素,在慢性肾脏病-矿物质骨异常（chronic kidney disease-mineral and bone disorder,CKDMBD）的发生发展中起着核心作用。了解PTH的体内代谢及检测方法有利于我们正确诊治CKD-MBD。1 PTH的体内合成、

作者甘良英

机构地区北京大学人民医院肾内科

出处《中国血液净化》 2016年第5期266-268,共3页 Chinese Journal of Blood Purification

基金北京市科学技术委员会首都临床特色应用研究支持项目项目编号:Z131107002213122 卫生公益性行业科研专项:优化尿毒症患者管理模式的研究201502010

关键词甲状旁腺激素钙磷代谢 PARATHYROID 体内代谢活性形式双抗体法免疫测定法试剂盒抗动物抗体甲状旁腺腺瘤

分类号 R318.16 [医药卫生—生物医学工程]

引文网络
相关文献

参考文献17

1D’Amour P. Circulating PTH molecular forms: what weknow and what we don’t[J]. Kidney Int, 2006, ?102):S29~33.
2Juppner H, Potts JT Jr. Immunoassays for the detectionof parathyroid hormone[J]. J Bone Miner Res, 2002, 17(Suppl 2):N81-86.
3Berson SA, Yalow RS, Aurbach GD, et al. Immunoassay ofbovine and human parathyroid hormone[J]. Proc NatlAcad Sci USA, 1963,49(5):613-617.
4Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highlysensitive two-site immunoradiometric assay of parathy-rin, and its clinical utility in evaluating patientswith hypercalcemia[J]. Clin Chem,1987,33(8):1364 - 1367.
5Lepage R, Roy L, Brossard JH, et al. A non- (1-84) cir-culating parathyroid hormone (PTH) fragment interferessignificantly with intact PTH commercial assay measure-ments in uremic samples[J]. Clin Chem, 1998,44(4):805-809.
6Nguyen-Yamamoto L, Rousseau L, Brossard JH, et al. Syn-thetic carboxyl-terminal fragments of parathyroid hor-mone (PTH) decrease ionized calcium concentration inrats by acting on a receptor different from the PTH/PTH-related peptide receptor[J]. Endocrinology, 2001,142 (4) :1386-1392.
7Langub MC, Monier-Faugere MC, Wang G, et al. Adminis-tration of PTH- (7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure[J],Endocrinology, 2003, 144(4):1135-1138.
8Wesseling-Perry K, Harkins GC, Wang HJ, et al. The cal-cemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies ac-cording to bone turnover: a potential role for PTH(7-84) [J]. J Clin Endocrinol Metab, 2010,95(6):2772-2780.
9D’Amour P, Brossard JH, Rousseau L, et al. Amino-termi-nal form of parathyroid hormone (PTH) with immunologicsimilarities to hPTH(l-84) is overproduced in primaryand secondary hyperparathyroidism[J]. Clin Chem, 2003,49(12):2037-2044.
10Donadio C, Ardini M, Lucchesi A, et al. Parathyroidhormone and large related O terminal fragments in-crease at different rates with worsening of renal func-tion in chronic kidney disease patients. A possible in-dicator of bone turnover status[J]. Clin Nephrol,2007, 67(3):131-139.